Device Cardiothoracic Pumps & Accessories

Dominant Flex, Vario

Payments companies reported to CMS as associated with Dominant Flex, Vario. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$415associated payments (2023-2025)
18clinicians with associated payments
1company reporting

By year

2025 $415

Payments reported as associated with Dominant Flex, Vario, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $166
Physician Assistant $103
Acute Care (Nurse Practitioner) $62.26
Pediatrics (Nurse Practitioner) $22.40
Family $22.40
Anesthesiology $19.73

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Dominant Flex, Vario

These are the largest totals companies reported as associated with Dominant Flex, Vario. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Awais Ashfaq Cincnnati, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $28.92
Mir Ali San Bernardino, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $26.30
Heather Whitmer San Bernardino, CA Physician Assistant $26.30
William Schlegel San Bernardino, CA Physician Assistant $26.30
Alexandra Kharazi Chula Vista, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $25.07
Alain Raymond Orange, CA Physician Assistant $25.06
Isabella Pecchia San Diego, CA Physician Assistant $25.06
Dongning Zhang Pomona, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $23.94
Gholam Mohammadzadeh Thousand Oaks, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $22.80
Gina Zelle Davenport, IA Acute Care (Nurse Practitioner) $22.80

Prescribed Dominant Flex, Vario?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.